4//SEC Filing
HedgePath Pharmaceuticals, Inc. 4
Accession 0000899243-17-007153
$INTICIK 0001042418operating
Filed
Mar 9, 7:00 PM ET
Accepted
Mar 10, 4:17 PM ET
Size
14.0 KB
Accession
0000899243-17-007153
Insider Transaction Report
Form 4
Hasara Garrison J.
CEO, Secretary & Treasurer
Transactions
- Tax Payment
Common Stock
2017-03-08$0.34/sh−1,470,478$499,963→ 4,059,044 total - Exercise/Conversion
Common Stock
2017-03-08+3,500,000→ 5,529,522 total - Exercise/Conversion
Restricted Stock Units
2017-03-08−3,500,000→ 0 total→ Common Stock (3,500,000 underlying) - Exercise/Conversion
Common Stock
2017-03-08+3,500,000→ 3,500,000 total - Tax Payment
Common Stock
2017-03-08$0.34/sh−1,470,478$499,963→ 2,029,522 total - Exercise/Conversion
Restricted Stock Units
2017-03-08−3,500,000→ 0 total→ Common Stock (3,500,000 underlying)
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") represents a right to receive one share of the issuer's common stock.
- [F2]The RSUs were issued to the reporting person on August 6, 2014, pursuant to a grant under the issuer's 2014 Equity Incentive Plan, and vested in accordance with their terms.
Documents
Issuer
HedgePath Pharmaceuticals, Inc.
CIK 0001042418
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001042418
Filing Metadata
- Form type
- 4
- Filed
- Mar 9, 7:00 PM ET
- Accepted
- Mar 10, 4:17 PM ET
- Size
- 14.0 KB